Article publié le16 janvier 2025par l’équipe médicale et paramédicale du site
Sources de l’article
- Kalamkas Sagandykova, Nataliya Papulova,Talapbek Azhenov,Aliya Darbekova,Bayan Aigozhina andJerome R. Lechien. Endoscopic Features of Chronic Rhinosinusitis in Patients with Gastroesophageal Reflux Disease. Medicina 2024.
- Gyawali, C.P.; Yadlapati, R.; Fass, R.; Katzka, D.; Pandolfino, J.; Savarino, E.; Sifrim, D.; Spechler, S.; Zerbib, F.; Fox, M.R.; et al. Updates to the modern diagnosis of GERD: Lyon consensus 2.0. Gut 2024.
- Chen, G.; Guo, W.; Liu, S.; Wang, Y.; Zhang, X. Causal analysis between gastroesophageal reflux disease and chronic rhinosinusitis. Eur. Arch. Otorhinolaryngol. 2024.
- Yeo, N.K.; Park, S.J.; An, T.H. Laryngopharyngeal reflux in chronic rhinosinusitis patients and the role of endoscopic sinus surgery. Auris Nasus Larynx 2022.
- Zeleník, K.; Javorská, Z.; Taimrová, R.; Vrtková, A.; Hránková, V.; Tedla, M.; Lukácová, K.; Lubojacký, J.; Formánek, M.; Komínek, P. Association Between Inferior Turbinate Hypertrophy and Extraesophageal Reflux. JAMA Otolaryngol. Head Neck Surg. 2022.
- Orlandi, R.R.; Kingdom, T.T.; Smith, T.L.; Bleier, B.; DeConde, A.; Luong, A.U.; Poetker, D.M.; Soler, Z.; Welch, K.C.; Wise, S.K.; et al. International consensus statement on allergy and rhinology: Rhinosinusitis 2021. Int. Forum Allergy Rhinol. 2021, 11, 213–739, Erratum in: Int. Forum Allergy Rhinol. 2022.
- Lechien, J.R.; Bobin, F.; Muls, V.; Mouawad, F.; Dapri, G.; Dequanter, D.; Horoi, M.; Thill, M.P.; Rodriguez Ruiz, A.; Saussez, S. Changes of Laryngeal and Extralaryngeal Symptoms and Findings in Laryngopharyngeal Reflux Patients. Laryngoscope 2021.
- Tai, J.; Han, M.; Kim, T.H. Therapeutic Strategies of Biologics in Chronic Rhinosinusitis: Current Options and Future Targets. Int. J. Mol. Sci. 2022.
- Fokkens, W.J.; Lund, V.J.; Hopkins, C.; Hellings, P.W.; Kern, R.; Reitsma, S.; Toppila-Salmi, S.; Bernal-Sprekelsen, M.; Mullol, J.; Alobid, I.; et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020.
- Lechien, J.R.; Rodriguez Ruiz, A.; Dequanter, D.; Bobin, F.; Mouawad, F.; Muls, V.; Huet, K.; Harmegnies, B.; Remacle, S.; Finck, C.; et al. Validity and Reliability of the Reflux Sign Assessment. Ann. Otol. Rhinol. Laryngol. 2020.
- Chong, L.Y.; Head, K.; Hopkins, C.; Philpott, C.; Schilder, A.G.; Burton, M.J. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Cochrane Database Syst. Rev. 2016.
- Bachert, C.; Han, J.K.; Desrosiers, M.; Hellings, P.W.; Amin, N.; Lee, S.E.; Mullol, J.; Greos, L.S.; Bosso, J.V.; Laidlaw, T.M.; et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): Results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 2019, 394, 1638–1650, Erratum in: Lancet 2019.
- Luo, H.N.; Yang, Q.M.; Sheng, Y.; Wang, Z.H.; Zhang, Q.; Yan, J.; Hou, J.; Zhu, K.; Cheng, Y.; Wang, B.T.; et al. Role of pepsin and pepsinogen: Linking laryngopharyngeal reflux with otitis media with effusion in children. Laryngoscope 2014.
- Ren, J.J.; Zhao, Y.; Wang, J.; Ren, X.; Xu, Y.; Tang, W.; He, Z. PepsinA as a Marker of Laryngopharyngeal Reflux Detected in Chronic Rhinosinusitis Patients. Otolaryngol. Head Neck Surg. 2017.